Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
38M
Number of holders
75
Total 13F shares, excl. options
30.1M
Shares change
+2.63M
Total reported value, excl. options
$1.03B
Value change
+$90.2M
Number of buys
49
Number of sells
-20
Price
$34.18

Significant Holders of ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q1 2021

84 filings reported holding ITOS - ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q1 2021.
ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30.1M shares of 38M outstanding shares and own 79.21% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.42M shares), BOXER CAPITAL, LLC (4.35M shares), MPM ASSET MANAGEMENT LLC (3.71M shares), RTW INVESTMENTS, LP (2.76M shares), MPM Oncology Impact Management LP (2.36M shares), BlackRock Inc. (1.53M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.26M shares), JANUS HENDERSON GROUP PLC (1.17M shares), ALLIANCEBERNSTEIN L.P. (1.17M shares), and Artal Group S.A. (1.09M shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.